| Bioactivity | Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. | ||||||||||||
| Invitro | Peimisine (17.43-92.07 μg/mL; 72 h) shows significant cytotoxic effects[3].Peimisine (15 μg/mL; 24, 48 and 72 h) induces G0/G1 phase arrest and rising apoptosis rate[3]. Apoptosis Analysis[3] Cell Line: | ||||||||||||
| Name | Peimisine | ||||||||||||
| CAS | 19773-24-1 | ||||||||||||
| Formula | C27H41NO3 | ||||||||||||
| Molar Mass | 427.62 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|